This book covers the scope of current knowledge of cancer in the LGBT community across the
entire cancer continuum from understanding risk and prevention strategies in LGBT groups
across issues of diagnosis and treatment of LGBT patients to unique aspects of survivorship
and death and dying in these communities. Each chapter includes an in depth analysis of the
state of the science discusses the many remaining challenges and unanswered questions and
makes recommendations for research policy and programmatic strategies required to address
these. Focus is also placed on the diversity of the LGBT communities.Issues that are unique to
cancer in LGBT populations are addressed including the social economic and cultural factors
that affect cancer risk behaviors barriers to screening utilization of health care services
and legislation that directly impacts the health care of LGBT patients healthcare settings
that are heterosexist and unique aspects of patient-provider relationships such as disclosure
of sexual orientation and the need for inclusion of expanded definition of family to include
families of choice.The implications of policy change its impact on healthcare for LGBT
patients are highlighted as are the remaining challenges that need to be addressed. A roadmap
for LGBT cancer prevention detection diagnosis survivorship including treatment and end of
life care is offered for future researchers policy makers advocates and health care
providers.
